针对古典霍奇金淋巴瘤的CAR-T细胞疗法
Mikalai Katsin1, Dmitri Dormeshkin2, Alexander Meleshko3
1Vitebsk Regional Clinical Cancer Centre, Vitebsk, Belarus.
HemaSphere
|November 29, 2023
概括
化学抗原受体T细胞 (CAR-T) 疗法对耐火性古典霍奇金淋巴瘤 (cHL) 有前途. 研究探讨了改善CAR-T疗效和cHL患者的安全性的目标和策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- 经典霍奇金淋巴瘤 (cHL) 是一种免疫细胞的癌症.
- 目前的治疗方法在一些cHL患者中失败,需要新的治疗方法.
- 霍奇金和里德-斯特恩伯格 (HRS) 细胞和瘤微环境 (TME) 是cHL的关键.
研究的目的:
- 为了审查cHL的发病性.
- 讨论在cHL中CAR-T细胞治疗的理由.
- 探索CAR-T细胞点和用于CHL治疗的策略.
主要方法:
- 对cHL病原和分子机制的审查.
- 在HRS细胞,B细胞和TME上识别潜在的CAR-T细胞标.
- 分析提高CAR-T细胞疗法的疗效和安全性的策略.
- 在cHL中进行CAR-T细胞治疗的临床试验结果的概述.
主要成果:
- 卡特-T细胞疗法是对cHL的有前途的治疗方法.
- 适合用于CAR-T细胞治疗的点包括CD30,CD19,CD20和LMP1/2A.
- 临床试验证明了CAR-T细胞治疗在cHL中的潜力.
结论:
- 卡特-T细胞疗法为CHL提供了一种新的治疗途径.
- 需要进一步的研究和临床试验,以优化对cHL的CAR-T细胞治疗.
- 卡特-T细胞疗法有可能改善耐火性cHL患者的治疗结果.
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K